People familiar with the matter revealed that China Pharmaceutical Group Co., Ltd. will restart the acquisition plan for China Chinese Medicine Holdings Co., Ltd., with a valuation of about $ 4 billion (about S $ 5.429 billion).
According to Bloomberg Society on Thursday (December 8) quoted people who are not well -known people, at present, Sinopharm Group is discussing a new proposal to privatize Chinese traditional Chinese medicine with consultants, that is, 6 Hong Kong dollars per share (about S $ 1.05 per share (about 1.05 yuan 1.05 yuan) Valuations privatize Chinese medicine in China, but have not made the final decision.
People familiar with the matter said that the acquisition offer may be proposed in the next few weeks that the review work is still ongoing, and the details of the quotation may change.
After the news came out, the stock price of Chinese Chinese medicine rose 17.2%on Thursday, soaring earlier by 28%, which is the biggest fluctuation in the market since 2013.The company's market value is HK $ 22.2 billion (about S $ 3.869 billion).
A spokesman for Chinese Chinese medicine responded that the company did not receive any information about the privatization of Chinese medicine group intending to conduct privatization of Chinese Chinese medicine, which was false information.The Sinopharm Group has not responded to the review request.
China Traditional Chinese Medicine has revealed in 2021 that Sinopharm Group is studying the privatization of the company, but in August of the same year, it was announced that Sinopharm Group decided not to promote this privatization plan.Sinopharm Group is the controlling shareholder of Chinese medicine, holding about 32%of Chinese Chinese medicine.
Bloomberg reported that if the transaction was established, it would be the largest privatization transaction of Hong Kong listed companies since the 2020 home appliance manufacturer Haier Electronic Group Co., Ltd. acquired GM for $ 5.4 billion.The transaction will bring nearly 60%of the investors in Chinese medicine.The closing price of Chinese Chinese Medicine Holdings on Wednesday (7th) was HK $ 3.77 per share.
